These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14511307)

  • 21. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
    Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
    Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired haemophilia A: an unusual postoperative complication.
    Arora S; Goyal G; Sarmad R; Wool KJ
    BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27852679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Register relevant to clinical practice.
    Baudo F; de Cataldo F;
    BJOG; 2003 Mar; 110(3):311-4. PubMed ID: 12628274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study.
    Zanon E; Milan M; Gamba G; Ambaglio C; Saggiorato G; Spiezia L; Montani N; Prandoni P
    Thromb Res; 2015 Dec; 136(6):1299-302. PubMed ID: 26505666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A.
    McFadyen JD; Tran H; Kaplan ZS
    Br J Haematol; 2017 Sep; 178(6):986-987. PubMed ID: 27431860
    [No Abstract]   [Full Text] [Related]  

  • 26. Transplacental transfer of postpartum inhibitors to factor VIII.
    Lulla RR; Allen GA; Zakarija A; Green D
    Haemophilia; 2010 Jan; 16(1):14-7. PubMed ID: 19500168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired hemophilia A in chronic lymphocytic leukemia: A case report.
    Karakuş V; Kaya E; Dere Y; Kurtoğlu E
    Transfus Apher Sci; 2019 Aug; 58(4):447-448. PubMed ID: 31320278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myelomonocytic leukaemia and acquired haemophilia A with severe cutaneous haemorrhage.
    Meek JC; Haak HL
    Scand J Haematol; 1986 Aug; 37(2):168-73. PubMed ID: 3094135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine recombinant factor VIII: an additional weapon to handle anti-factor VIII antibodies.
    Mannucci PM; Franchini M
    Blood Transfus; 2017 Jul; 15(4):365-368. PubMed ID: 27483484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries.
    Pekçelen Y; Yavuz AS; Namli S; Gücükoglu A
    Blood Coagul Fibrinolysis; 2005 Sep; 16(6):445-6. PubMed ID: 16093736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors].
    Kawasaki Y; Saeki N; Kawamoto M; Yuge O; Fujii T
    Masui; 2005 Aug; 54(8):926-8. PubMed ID: 16104555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A.
    Franchini M; Girelli D; Olivieri O; Castaman G; Lippi G; Poli G; Salvagno GL; Tagariello G; Giuffrida A; de Gironcoli M; Morfini M; Berntorp E; Gandini G
    Haemophilia; 2006 Jul; 12(4):448-51. PubMed ID: 16834751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High titre inhibitor to factor VIII in a haemophilia carrier.
    Marino R; Malcangi G; Margaglione M; Ettorre CP
    Haemophilia; 2014 May; 20(3):e237-40. PubMed ID: 24731130
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.
    von Depka M
    Haemophilia; 2005 Nov; 11 Suppl 1():18-23. PubMed ID: 16219045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience.
    Tjønnfjord GE
    Haemophilia; 2004 Sep; 10 Suppl 2():41-5. PubMed ID: 15385045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches to using FEIBA in the treatment of inhibitor patients.
    Berntorp E; Gringeri A; Leissinger C; Négrier C; Key N
    Semin Thromb Hemost; 2006 Jun; 32 Suppl 2():22-7. PubMed ID: 16804832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.